# Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE)

> **NCT02425592** · — · COMPLETED · sponsor: **Yale University** · enrollment: 223 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02425592
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2022-05-30
- **Final completion:** 2025-05
- **Target enrollment:** 223 (ACTUAL)
- **Last updated:** 2025-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02425592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02425592, "Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02425592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*